Last reviewed · How we verify

NCT05326893

The Preventive Effects of Neurodynamic Mobilisation

Completed NA Last updated 4 November 2024
What this trial tests

NA trial testing Femoral nerve neurodynamic mobilization in Delayed Onset Muscle Soreness in 34 participants. Completed in 13 May 2022.

Timeline
20 February 2020
Primary endpoint
20 October 2020
13 May 2022

Quick facts

Lead sponsorUğur Sözlü
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment34
Start date20 February 2020
Primary completion20 October 2020
Estimated completion13 May 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Uğur Sözlü

Who can join

Adults 18 to 32, male only, with Delayed Onset Muscle Soreness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the study, 34 healthy sedentary male volunteers were randomly divided into two groups as NM (n = 17) and SHAM-NM (n = 17). After the initial evaluation of the individuals, femoral nerve NM and placebo NM techniques were administered three sets a day with ten repetitions for three days a week for three weeks. Three days after the end of the applications, the second evaluations were made and the DOMS creation protocol for the quadriceps femoris (QF) muscle was initiated. In order to trigger DOMS in individuals, 30 sets and 10 repetitions of eccentric knee extension (35°-95° flexion angles, 30°/sec speed) were performed on the dominant lower extremity with an isokinetic dynamometer. Baseline evaluations were repeated immediately after the DOMS protocol, and at hours 24, 48, and 72. During evaluations, muscle damage (serum creatine kinase (CK), lactate dehydrogenase (LDH), and inflammation (interleukin-6 (IL-6), tumor necrosis factor-alpha) biomarkers, pain (activity), pressure pain threshold, and performance (one-leg jump, vertical jump) parameters were measured.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Preventive effect of the neurodynamic mobilization technique on delayed onset of muscle soreness: a randomized, single-blinded, placebo-controlled study.
    Sozlu U, Basar S, Semsi R, Akaras E, et al · · 2025 · cited 2× · PMID 40349018 · DOI 10.1186/s12891-025-08723-8

Verify or expand the search:

Other recruiting trials for Delayed Onset Muscle Soreness

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05326893.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing